DIVISLAB — Divi's Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Divi's Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,145	20,303	12,148	1,697	39,870
Net Total Accounts Receivable
Net Total Receivables	16,812	18,198	25,896	20,372	21,840
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	46,798	61,747	83,515	93,117	96,750
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	36,979	44,095	47,875	49,292	55,130
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	85,357	107,741	133,747	144,388	154,700
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9,268	11,125	11,956	11,011	12,780
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	12,258	14,795	16,465	16,717	18,990
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	73,099	92,946	117,282	127,671	135,710
Total Liabilities & Shareholders' Equity	85,357	107,741	133,747	144,388	154,700
Total Common Shares Outstanding